B-cell receptor signaling
Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study
13
Racial differences in B cell receptor signaling pathway activation
7
Targeting early B-cell receptor signaling induces apoptosis in leukemic mantle cell lymphoma
14
B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling
10
Correlations of gene expression with ratings of inattention and hyperactivity/impulsivity in tourette syndrome: a pilot study
8
NF-κB signaling and its relevance to the treatment of mantle cell lymphoma
11
Drug Modulators of B Cell Signaling Pathways and Epstein-Barr Virus Lytic Activation
13
Viral Modulation of T-Cell Receptor Signaling
11
Potential role of LINC00996 in colorectal cancer: a study based on data mining and bioinformatics
11
B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy
9
CD95 Signaling Inhibits B Cell Receptor-Mediated Gammaherpesvirus Replication in Apoptosis-Resistant B Lymphoma Cells
15
Syk inhibitors in clinical development for hematological malignancies
7
Effects of vitamin D3 and its chemical analogs on the growth of Hodgkin’s lymphoma, in vitro
6
Toll-Like Receptor 9 and Interferon-Gamma Receptor Signaling Suppress the B Cell Fate of Uncommitted Progenitors in Mice
100
Targeting CD22 with the monoclonal antibody epratuzumab modulates human B cell maturation and cytokine production in response to Toll like receptor 7 (TLR7) and B cell receptor (BCR) signaling
18
Epstein-Barr virus LMP2A signaling in statu nascendi mimics a B cell antigen receptor-like activation signal
11
Antigen receptor signaling in the rheumatic diseases
9
Cell autonomous and cell non autonomous signaling through endothelin receptor B during melanocyte development
9
Heterogeneity of Toll like receptor 9 signaling in B cell malignancies and its potential therapeutic application
10
Original Article Pathway analysis of esophageal squamous cell carcinoma using iTRAQ-based quantitative proteomic approach
8